About John DeFord
John DeFord is a co-founder, CEO and chairman of the board at Samothrace Medical Innovations.
Form D filings also name John DeFord as a director at Enable Injections.
Experience
This experience comes from John DeFord's profile and from SEC filings. For roles taken from filings, the years are when the filings name John DeFord in the role, so the role may have started earlier or lasted longer.
PH
Philips Current
Supervisory Board Member
2026 – Present
Samothrace Medical Innovations Inc. Current
Co-founder, CEO and Chairman of the Board
Executive Chair Samothrace Medical Innovations, Inc. (2022 – Present)
2022 – Present · Daniel Island, SC
Develops minimally invasive devices for diagnosing and treating bowel disease.
ML
Maravai LifeSciences Current
Board Member
2022 – Present
NC
Nordson Corporation Current
Board Member
2020 – Present
GM
Globus Medical
Board Member
2023 – 2026
BD
Becton Dickinson
EVP and CTO (Retired)
2018 – 2021
CB
CR Bard
SVP, Science, Technology & Clinical Affairs (2007 – 2017)
VP, Science & Technology (2004 – 2007)
2004 – 2017
Key Colleagues at Startups
The people John DeFord works with at each company, as listed on that company's latest Form D.
Samothrace Medical Innovations Inc. · Form D, Aug 21, 2026
GK
Ghassan Kassab
Co-founder, Board Member
MB
Michael Bunker
Director
Enable Injections, Inc. · Form D, Jan 9, 2026
JC
Jim Collins
Director
SS
Simone Song
Director
RA
Richard D'Augustine
Director
JR
John Rice
Director
DK
David Kroekel
Executive officer
MH
Matt Huddleston
Executive officer
TF
Timothy Flaherty
Chief Financial Officer
BR
Beckie Robertson
Director
MH
Michael Hooven
Executive officer and director
EF
Erik Falk
Director
NS
Nigel Sheail
Director
VC
Vickie Capps
Director